Most children are not being adequately vaccinated against influenza, according to new data from the Centers for Disease Control and Prevention (CDC), which also just published a new report demonstrating the efficacy of the vaccine in reducing influenza-related deaths in children.

Despite controversy surrounding the human papillomavirus (HPV) vaccine, more adolescents and young adults are getting vaccinated. However, overall vaccination rates of HPV compared with other teenaged-years vaccines are still low, says the Centers for Disease Control and Prevention (CDC).

Findings of a recently published observational retrospective cohort study point to a need for increased efforts to improve timely completion of the human papillomavirus (HPV) vaccine series among boys.

A congressional fact of life is the dangerous “Christmas tree” bill, which passes with so much on it that many things don’t get the scrutiny they deserve. The 21st Century Cures Act, signed into law by President Obama on December 13, 2016, is such a bill.

The Advisory Committee on Immunization Practices (ACIP) has updated the federal immunization guidelines, including more nuances of the guidelines visually represented on the schedule to enhance clarity.

After a poor matchup to circulating viruses in the 2014-2015 season, the Centers for Disease Control and Prevention (CDC) has released a new vaccine for this year, along with updated administration guidelines.

In June, the Advisory Committee on Immunization Practices (ACIP) declined to recommend that a newly approved serogroup B meningococcal (MenB) vaccine series be used universally in adolescents aged 16 to 18 years, basically leaving the decision up to parents and providers.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices discussed vaccination for serogroup B meningococcal disease (MenB) at its June 2015 meeting and voted its recommendation. What does ACIP’s decision mean for your practice?